Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FAZHN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The contract carries a firm fixed-price structure with an ultimate completion date of June 23, 2025, and no set-aside designation was used in the award. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and specialty pharmaceutical products to Department of Defense healthcare facilities nationwide. The company's established contract portfolio with the Defense Logistics Agency demonstrates consistent success in securing awards for an extensive range of pharmaceutical items, including biologics, branded and generic prescription drugs, and medical consumables. Stelara, a biologic medication commonly used for immunological conditions, represents one of the specialized pharmaceutical products within the company's delivery portfolio to support military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FAZHN?
SPE2DB25FAZHN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FAZHN worth?
The government has obligated $16,250 on SPE2DB25FAZHN.
Is contract SPE2DB25FAZHN an order under another contract?
Yes. SPE2DB25FAZHN is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZHN competed?
The extent of competition for SPE2DB25FAZHN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award